CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
3 research outputs found
Randomized phase II study of weekly paclitaxel with or without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA HER2-negative breast cancer.
Author
Hideko Yamauchi
Hiroji Iwata
+14 more
Hitoshi Tsuda
Jun Hashimoto
Katsumasa Kuroi
Kenichi Inoue
Kenji Tamura
Kenjiro Aogi
Masashi Andoh
Masayuki Yoshida
Naohito Yamamoto
Norikazu Masuda
Satoru Shimizu
Shinji Ohno
Tamie Sukigara
Yasuhiro Fujiwara
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
A phase I/II trial of olaparib in combination with eribulin in patients with advanced or metastatic triple negative breast cancer (TNBC) previously treated with anthracyclines and taxanes: First results from phase I.
Author
Akinobu Hamada
Harukaze Yamamoto
+14 more
Hiroyuki Yasojima
Kan Yonemori
Kenji Tamura
Kenjiro Aogi
Kiyomi Higuchi
Masahiro Takeuchi
Masato Takahashi
Norikazu Masuda
Rie Nakano
Ritsuko Nagasaka
Tamie Sukigara
Yasuhiro Fujiwara
Yuka Morioka
Yukie Tsujimoto
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
MASTER KEY project: A basket/umbrella trial for rare cancers in Japan.
Author
Akihiro Hirakawa
Akira Kawai
+18 more
Chigusa Morizane
Emi Noguchi
Hitomi Sumiyoshi Okuma
Kan Yonemori
Kazuki Sudo
Kenichi Nakamura
Kuniko Sunami
Noboru Yamamoto
Nobuyoshi Hiraoka
Takashi Kohno
Tamie Sukigara
Taro Shibata
Toshio Shimizu
Toshirou Nishida
Wataru Munakata
Yasuhiro Fujiwara
Yasushi Goto
Yoshitaka Honma
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref